Aadi Bioscience Inc. (AADI)
2.31
-0.25 (-9.77%)
At close: Mar 03, 2025, 3:59 PM
2.41
4.56%
After-hours: Mar 03, 2025, 07:17 PM EST
Aadi Bioscience Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Cash & Equivalents | 62.89M | 39.02M | 148.99M | 4.46M | 38.52M | 62.61M | 20.26M | 1.61M | 5.14M | 5.26K | 6.28K | 4.61K | 4.13K | 26.9K | 11.14K | 7.51K |
Short-Term Investments | 45.96M | 133.54M | n/a | n/a | n/a | n/a | n/a | 50K | 50K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.87M | 2.11M | 2.21M | -140K | 40K | 40.96K | 20.96K | 20.96K | 20.96K | n/a | 2.5K | n/a | n/a | n/a | n/a | n/a |
Receivables | 5.49M | 1.86M | n/a | 14.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 6.43M | 1.86M | n/a | n/a | -284.9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.83M | 3.75M | 4.57M | 81K | 793.66K | 1.37M | 635.36K | 566.63K | 771.39K | n/a | n/a | 3.5K | 2.5K | n/a | n/a | n/a |
Total Current Assets | 124.59M | 180.03M | 151.27M | 18.68M | 39.57M | 63.98M | 20.9M | 2.23M | 5.97M | 5.26K | 6.28K | 8.11K | 6.63K | 26.9K | 11.14K | 7.51K |
Property-Plant & Equipment | 5.97M | 2.03M | 614K | 140K | 326.31K | 98.45K | 107.22K | 149.59K | 105.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | 3.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 7.84M | 4.21M | 6.64M | 140K | 366.31K | 139.41K | 128.18K | 170.56K | 126.93K | n/a | 2.5K | n/a | n/a | n/a | n/a | n/a |
Total Assets | 132.42M | 184.24M | 157.91M | 18.82M | 39.94M | 64.12M | 21.03M | 2.4M | 6.09M | 5.26K | 8.78K | 8.11K | 6.63K | 29.4K | 13.02K | 7.51K |
Account Payables | 5.9M | 3.52M | 6.44M | 2.39M | 439.79K | 595.68K | 1.28M | 4.27K | 3.67K | 2.4K | 350.00 | 1.85K | 2.98K | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | 18.41M | n/a | n/a | n/a | -4.27K | -163.67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 434K | 788K | 131K | 9.15M | 290.83K | n/a | n/a | 12.39M | 160K | 125K | 110K | 85K | 60K | 60K | 25K | n/a |
Other Current Liabilities | 20.06M | 14.53M | 8.7M | 18.51M | 2.6M | 4.86M | 2.32M | 2.47M | 2.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 26.39M | 18.84M | 15.27M | 30.06M | 3.33M | 5.46M | 3.59M | 14.86M | 2.16M | 160.3K | 133.03K | 103.65K | 74.8K | 60K | 25K | n/a |
Long-Term Debt | 833K | 1.27M | 474K | 1.1M | 67.44K | n/a | n/a | n/a | n/a | 125K | 110K | 85K | 60K | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 5.76M | 5.76M | 97K | n/a | n/a | n/a | 55.65K | 41.34K | -92.1K | -87.33K | -68.2K | -48.18K | 10.39K | 6.61K | n/a |
Total Long-Term Liabilities | 833K | 7.02M | 6.23M | 1.2M | 67.44K | n/a | n/a | 55.65K | 41.34K | 125K | 110K | 85K | 60K | 10.39K | 6.61K | n/a |
Total Liabilities | 27.23M | 25.86M | 21.5M | 31.26M | 3.4M | 5.46M | 3.59M | 14.86M | 2.16M | 160.3K | 133.03K | 103.65K | 74.8K | 70.39K | 31.61K | n/a |
Total Debt | 1.27M | 1.66M | 605K | 10.26M | 169.99K | n/a | n/a | 12.39M | 160K | 250K | 220K | 170K | 120K | 60K | 25K | n/a |
Common Stock | 2K | 2K | 2K | 1K | 4.06K | 4.06K | 2.71K | 29.00 | 27.00 | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 | n/a |
Retained Earnings | -268.96M | -203.2M | -142.69M | -32.59M | -142.24M | -118.96M | -108.56M | -86.22M | -66.55M | -205.04K | -174.24K | -145.54K | -118.18K | -90.99K | -68.6K | -48.6K |
Comprehensive Income | 27K | -115K | n/a | n/a | -328.85K | -311.13K | -335.85K | -29 | -27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 105.19M | 158.38M | 136.41M | -12.43M | 36.54M | 58.67M | 17.44M | -12.46M | 3.93M | -155.04K | -124.24K | -95.54K | -68.18K | -40.99K | -18.6K | 1.4K |
Total Investments | 45.96M | 133.54M | n/a | n/a | n/a | n/a | n/a | 50K | 50K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |